Provera Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Medroxyprogesterone acetate

Indications/Uses

Secondary amenorrhea. Abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology (eg, fibroids or uterine cancer).

Dosage/Direction for Use

Secondary amenorrhea 5-10 mg daily for 5-10 days. Abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology 5-10 mg daily for 5-10 days from day 16 or 21 of the menstrual cycle.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Undiagnosed vag bleeding. Thrombophlebitis. Thromboembolic disorders. Cerebral apoplexy or patients w/ history of these conditions. Missed abortion. Known or suspected malignancy of the breast. Severe liver dysfunction. Pregnancy.

MIMS Class

Oestrogens, Progesterones & Related Synthetic Drugs

ATC Classification

G03DA02 - medroxyprogesterone ; Belongs to the class of pregnen (4) derivative progestogens.

Regulatory Classification

POM

Presentation/Packing

Form

Provera tab 10 mg

Packing/Price

1's

Form

Provera tab 5 mg

Packing/Price

1's

Provera

medroxyprogesterone

Manufacturer:

Pfizer Italia S.r.l.